Alphageneron Pharmaceuticals
New York, US · Founded 2020 · Delaware corporation
Founders & leadership
RB
Robert BrooksNamed on SEC filing
OS
Ola SoderquistNamed on SEC filing
ML
Marc LippmanNamed on SEC filing
BV
Bikash VermaNamed on SEC filing
RC
Robert ClarkeNamed on SEC filing
GP
Graham PockleyNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$250K disclosed across 1 round · 2023
▶$250KraisedAug 2023 · 1 investors · PharmaceuticalsRule 506(b)
▶$250KraisedAug 2023 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Robert BrooksExecutive Officer, Director
- Ola SoderquistExecutive Officer
- Marc LippmanDirector
- Bikash VermaDirector
- Robert ClarkeDirector
- Graham PockleyExecutive Officer
- Offering amount
- $250K
- Amount sold
- $250K
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Alphageneron Pharmaceuticals raised?
- Alphageneron Pharmaceuticals has disclosed $250K raised across 1 round.
- Where is Alphageneron Pharmaceuticals headquartered?
- Alphageneron Pharmaceuticals is headquartered in New York, US.